Motley Fool "Rule Breaker" Guardant Health (GH) just popped a classic buy signal with a new high on a 500% increase in volume.
The company will seek FDA approval (already has pre-market approval) for it's testing device that detects cancer and determines the type with a simple blood test.
The company will seek FDA approval (already has pre-market approval) for it's testing device that detects cancer and determines the type with a simple blood test.
